Acquired antithrombin deficiency in adult patients with postcardiotomy extracorporeal membrane oxygenation
Perfusion · 2025
DOI: 10.1177/02676591241279764 ↗Kurz gefasst
Fachartikel in der Zeitschrift Perfusion, 2025. Verfasst von Arif Yasin Cakmak und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery, Sanliurfa Training and Research Hospital, Sanliurfa, Turkey. Hauptthemen laut MEDLINE: Extracorporeal Membrane Oxygenation, Cardiac Surgical Procedures, Antithrombin III Deficiency. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
Introduction
This study aimed to investigate the relationship between acquired antithrombin deficiency in patients undergoing postcardiotomy extracorporeal membrane oxygenation (PC-ECMO) and thromboembolic or haemorrhagic events such as bleeding, peripheral arterial thromboembolism, and ischemic cerebrovascular events.
Methods
The study was designed as a single-center, prospective study and conducted at our hospital between November 2019 and June 2021. 50 patients who underwent ECMO due to postcardiotomy cardiogenic shock were included in the study. Antithrombin (AT) activity testing was performed immediately after ECMO placement and continued for 5 days. The total of haemorrhagic or thromboembolic events was defined as morbidity. The entire patient population was assessed daily for AT measurements according to morbidity status, and ROC analysis was applied to determine the cut-off point. The correlation between clinical outcomes and morbidities with antithrombin levels was analysed.
Results
In our study, we identified a cut-off for AT levels on the first postoperative day. The risk of both bleeding ( p = .006) and thromboembolism ( p = .012) was significantly higher in patients below the 48.9% cut-off value. AT levels were compared with data on separation from PC-ECMO. The rate of separation from ECMO was 7.969 times higher in cases with AT levels above 51.8 on the third postoperative day and 5.6 times higher in cases with AT levels above 47.5 on the fourth postoperative day.
Conclusion
Acquired antithrombin deficiency may develop in adults undergoing PC-ECMO. In our study, we demonstrated that in patients with low antithrombin levels, the risk of bleeding and thromboembolism increased. Additionally, since AT levels were higher in survivors, this can be considered an indicator of severity. This study is the first prospective study related to determining target antithrombin levels in adult patients undergoing PC-ECMO.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiovascular Surgery, Sanliurfa Training and Research Hospital, Sanliurfa, Turkey.
- Department of Cardiovascular Surgery, Dr Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital, Istanbul, Turkey.
- Department of Cardiovascular Surgery, Kırklareli Training and Research Hospital, Kırklareli, Turkey.
- Department of Department of Anesthesiology, Dr Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital, Istanbul, Turkey.
ORCID-Profile: Arif Yasin Cakmak, Sevinç Bayer Erdoğan
Zitieren
APA
Cakmak, A. Y., Erdoğan, S. B., Sargın, M., Er, H., Usca, M. K., Hasbal, B., Yapıcı, N., & Aka, S. A. (2025). Acquired antithrombin deficiency in adult patients with postcardiotomy extracorporeal membrane oxygenation. Perfusion. https://doi.org/10.1177/02676591241279764
Vancouver
Cakmak AY, Erdoğan SB, Sargın M, Er H, Usca MK, Hasbal B, et al. Acquired antithrombin deficiency in adult patients with postcardiotomy extracorporeal membrane oxygenation. Perfusion. 2025. doi:10.1177/02676591241279764
BibTeX
@article{Cakmak2025,
author = {Cakmak, Arif Yasin and Erdoğan, Sevinç Bayer and Sargın, Murat and Er, Halit and Usca, Mehmet Kağan and Hasbal, Berat and Yapıcı, Nihan and Aka, Serap Aykut},
title = {Acquired antithrombin deficiency in adult patients with postcardiotomy extracorporeal membrane oxygenation},
journal = {Perfusion},
year = {2025},
doi = {10.1177/02676591241279764}
}
EUVIMED